The World: Pittsburgh - Bayer sued after making prostate cancer claim

The Centre for Science in the Public Interest has filed a lawsuit against the multinational pharmaceutical company Bayer over ads claiming its multivitamin, One A Day Men's, could reduce prostate cancer.

Bayer's marketing claimed the selenium in its product could reduce the risk of the disease.

In a statement, the CSPI said it contacted Bayer in June with proof that selenium does not have the desired effect on prostate cancer.


Become a member of Campaign

Get the very latest news and insight from Campaign with unrestricted access to, plus get exclusive discounts to Campaign events.

Become a member

What is Campaign AI?

Our new premium service offering bespoke monitoring reports for your company.

Find out more

Looking for a new job?

Get the latest creative jobs in advertising, media, marketing and digital delivered directly to your inbox each day.

Create an alert now

Partner content